Allergy and hypersensitivity Flashcards

1
Q

what is a type 1 hypersensitivity reaction?

A

Type I hypersensitivity is an immediate reaction to environmental antigens mediated via IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is atophy?

A

Atopy is an inherited trait for Type I hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are allergens?

A

Allergens are antigens that trigger allergic reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what effect does histamine have?

A

Vasodilatation, increased capillary permeability, chemokinesis, bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what effect does neutral proteases ( try-gases, chemises and carboxypeptidase A) have?

A

Increased vascular permeability, airway hyperresponsiveness, cell recruitment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what effect does proteoglycan have?

A

Binds granule proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what effect does neutral proteases such as b-glucosaminidase have?

A

Activates C3
Splits off glucosamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the main areas exposed to antigens?

A

skin, gi tract and lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what effect do Eosinophil chemotactic factors and Neutrophil chemotactic factors have?

A

eosinophil chemotaxis
neutrophil chemotaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what effect do platelet activating factor have?

A

mediator release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what effect does IL – 3, 4, 5 & 6 GM-CSF, TNF have?

A

Macrophage activation, trigger acute phase proteins etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what newly synthesised product does the lipoxygenase pathway include?

A

Leukotrienes C4, D4, B4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the effect of the lipoxygenase pathway?

A

Vasoactive, bronchoconstriction, chemotaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the newly synthesised product in the cycle-oxygenase pathway?

A

Prostaglandins Thromboxanes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what effect does the cyclo-oxygenase pathway have?

A

Affect bronchial muscle, platelet aggregation and vasodilatation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

clinical manifestations of allergy

A

trouble breathing
itching
sneezing
runny nose
headache
red or watery eyes
hives or rash

17
Q

What are the conditions that elicit a type I hypersensitivity reaction?

A

 Allergen characteristics
 Host factors
 Environmental influences

18
Q

What makes certain proteins allergenic?

A

 Allergens have the ability to induce a strong IgE response
 Protease activity – Der p 1
 Surface features of protein – Ves v 5
 Glycosylation pattern of protein – Ara h 1

19
Q

The clinical manifestations

A

 Allergic rhinitis
 Allergic conjunctivitis  Atopic dermatitis
 Urticaria/angioedema  Asthma
 Food allergy
 Drug allergy
 Venom allergy
 Anaphylaxis

20
Q

Treatment options

A

 Anaphylaxis is a medical emergency  Treatment consists of:
 Adrenaline / epinephrine
 Antihistamines
 Corticosteroids
 Fluid resuscitation
 Bronchodilation
 Other treatment options include:  Allergen avoidance
 Topical corticosteroids
 Antihistamines

21
Q

what is Desensitisation or allergen-specific immunotherapy?

A

A process whereby the immune system is exposed to gradually increasing doses of allergen in order to develop tolerance

22
Q

how is Desensitisation or allergen-specific immunotherapy administered?

A

via subcutaneous or sublingual route

23
Q

when is Desensitisation or allergen-specific immunotherapy used?

A

Used in allergic rhinitis, venom allergy and drug allergies predominantly

24
Q

describe asthma

A

Partially a type I hypersensitivity phenomenon but also has type IV (cell mediated) and type V (tissue driven) mechanisms

 Large proportion of asthmatics have T2-hi inflammation
 Numerous monoclonal antibodies available